Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Veracruz
Clinical trial register · Mexico

Clinical Trials in Veracruz, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 591 Monterrey 374 Guadalajara 348 Chihuahua City 175 Mérida 133
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Pfizer13 Sanofi11 Eli Lilly and Company10 AstraZeneca6 Bristol-Myers Squibb4
Site location
Mexico City591 Monterrey374 Guadalajara348 Chihuahua City175 Mérida133
All 197 locations
Target enrolment
to

Trials with a site in Veracruz

91 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Not yet open
Cardiovascular Risk Factors in Mexican Women
NCT07863674Cardiovascular Risk Factors, Cardiovascular Diseases
Medicaweb, S.A.C.V.
Observational
3,000
Mexico City, Monterrey, Veracruz
2026-11
Recruiting
Hoffmann-La Roche
Phase 3
100
Mexico City, Veracruz
2026-08-18
Recruiting
Eli Lilly and Company
Phase 3
1,000
Chihuahua City, Ciudad de Tijuana, Cuernavaca, Culiacán, Mexico City, Mérida, Veracruz, Zapopan
2026-08-14
Recruiting
Eli Lilly and Company
Phase 2
342
Ciudad de Tijuana, Mexico City, Mérida, Torreón, Veracruz, Zapopan
2026-04-29
Recruiting
Eli Lilly and Company
Phase 3
1,000
Chihuahua City, Guadalajara, Mazatlán, Mexico City, Mérida, Morelia, Veracruz
2026-02-09
Recruiting
Bristol-Myers Squibb
Phase 3
366
Zapopan, Mexico City, Monterrey, Chihuahua City, Mérida, Toluca, Veracruz
2025-12-03
Recruiting
Pfizer
Phase 3
500
Mexico City, Monterrey, Veracruz, Chihuahua City
2025-12-02
Recruiting
Takeda
Phase 2
200
Monterrey, Morelia, Veracruz
2025-11-03
Recruiting
Eli Lilly and Company
Phase 2
531
Aguascalientes, Chihuahua City, Durango, Guadalajara, Mérida, Morelia, Querétaro, Veracruz
2025-10-22
Recruiting
Genentech, Inc.
Phase 2
224
Guadalajara, Tlajomulco de Zúñiga, Mérida, San Luis Potosí City, Veracruz
2025-09-29
Recruiting
Sanofi
Phase 3
942
Monterrey, San Juan del Río, Durango, Mexico City, Veracruz
2025-09-16
Recruiting
Pfizer
Phase 3
6,000
Guadalajara, Mexico City, Monterrey, San Juan del Río, Veracruz
2025-08-25
Recruiting
Pfizer
Phase 3
150
Mexico City, Monterrey, Veracruz, Chihuahua City
2025-07-24
Recruiting
Pfizer
Phase 3
300
San Pedro Garza García, Veracruz, Mexico City
2025-07-14
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Saltillo, Mexico City, Pachuca, Guadalajara, Monterrey, Chihuahua City, Puebla City, Veracruz
2025-04-24
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Colonia del Valle, Culiacán, Tlalpan, Veracruz
2025-03-18
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
4,000
Veracruz
2025-03-01
Recruiting
Summit Therapeutics
Phase 3
780
Aguascalientes, Guadalajara, Querétaro, Oaxaca City, Jalisco, Mexico City, Monterrey, Veracruz
2025-02-27
Active, closed
Sanofi
Phase 3
216
Guadalajara, Monterrey, Chihuahua City, Veracruz
2025-02-06
Recruiting
GlaxoSmithKline
Phase 3
1,840
Acapulco, Hidalgo, Mexico City, Veracruz
2025-01-10
Recruiting
Eli Lilly and Company
Phase 3
55
Ciudad Madero, Puebla City, Tampico, Tlalpan, Veracruz
2025-01-10
Active, closed
Hoffmann-La Roche
Phase 3
350
Miguel Hidalgo, Veracruz
2024-12-11
Recruiting
Pfizer
Phase 3
2,330
León, Pachuca, Cuernavaca, Monterrey, Mexico City, Veracruz
2024-12-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
León, Guadalajara, Mexico City, Cuernavaca, Monterrey, Mérida, Chihuahua City, Veracruz
2024-12-02
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Acapulco de Juárez, Col. Xoco, Cuernavaca, Mexico City, Mérida, Veracruz, Xalapa
2024-11-12
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Acapulco de Juárez, Col. Xoco, Cuernavaca, Mexico City, Mérida, Veracruz, Xalapa
2024-10-14
By invitation
Sanofi
Phase 2
900
Monterrey, San Juan del Río, Mérida, Chihuahua City, Durango, Veracruz
2024-09-30
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Veracruz
2024-08-30
Recruiting
AbbVie
Phase 3
675
Monterrey, Veracruz
2024-08-19
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Mexico City, Monterrey, Obispado, Sinaloa, Tlalnepantla, Veracruz
2024-07-30
Active, closed
Celldex Therapeutics
Phase 3
976
Chihuahua City, Cuauhtémoc, Guadalajara, Mérida, Monterrey, Morelia, San Juan del Río, Veracruz
2024-07-19
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Guadalajara, Culiacán, Veracruz
2024-07-12
Active, closed
AstraZeneca
Phase 3
339
Guadalajara, Mexico City, Veracruz
2024-06-29
Active, closed
AbbVie
Phase 3
1,400
Guadalajara, Mexico City, Monterrey, Veracruz
2024-06-27
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Aguascalientes, Cuernavaca, Monterrey, Veracruz
2024-05-20
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Mexico City, Monterrey, Obispado, Sinaloa, Tlalnepantla, Veracruz
2024-05-13
Active, closed
Sanofi
Phase 3
1,541
Monterrey, Aguascalientes, Durango, Veracruz
2024-05-08
Active, closed
Eli Lilly and Company
Phase 3
320
Chihuahua City, Guadalajara, Mérida, Veracruz
2024-03-15
Active, closed
Sanofi
Phase 3
464
Monterrey, Veracruz
2024-02-29
Recruiting
University of Edinburgh
Observational
1,332
Veracruz
2024-02-28
Active, closed
Eli Lilly and Company
Phase 3
1,250
Guadalajara, Mexico City, Cuernavaca, Monterrey, Chihuahua City, Veracruz
2024-02-21
Recruiting
Novartis Pharmaceuticals
Phase 2
108
Oaxaca City, Veracruz
2024-02-20
Active, closed
Boehringer Ingelheim
Phase 3
428
Mexico City, México, Veracruz
2024-02-09
Active, closed
Pfizer
Phase 3
394
Mexico City, Monterrey, Veracruz
2024-01-19
Active, closed
Pfizer
Phase 2
333
Mexico City, Monterrey, Oaxaca City, Veracruz
2024-01-09
By invitation
Sanofi
Phase 3
90
San Juan del Río, Durango, Veracruz
2024-01-03
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
DrugZipalertinib
Taiho Oncology, Inc.
Phase 3
285
Aguascalientes, Guadalajara, Mexico City, Mirador, Veracruz
2023-12-18
Active, closed
Sanofi
Phase 3
1,655
Guadalajara, Monterrey, Culiacán, Mérida, Mexico City, Tlalnepantla, Veracruz
2023-12-13
Active, closed
Pfizer
Phase 3
1,571
Mexico City, Morelia, Monterrey, Chihuahua City, Veracruz
2023-11-08
Active, closed
AstraZeneca
Phase 3
5,511
Alc. Cuauhtémoc, Mérida, San Luis Potosí City, Tuxtla Gutiérrez, Veracruz
2023-10-05
Active, closed
Hyponatremia Volume Status Analysis by Point-of-care Ultrasound
NCT06013800Hyponatremia, Water-Electrolyte Imbalance
Universidad Veracruzana
Observational
80
Veracruz
2023-10-01
Recruiting
Gilead Sciences
Phase 3
402
Cuernavaca, Irapuato, Mexico City, México, Oaxaca City, Veracruz
2023-09-07
Recruiting
AstraZeneca
Phase 3
231
Chihuahua City, Guadalajara, Mexico City, Veracruz
2023-08-24
By invitation
Eli Lilly and Company
Phase 3
333
Chihuahua City, Zapopan, Mexico City, Cuernavaca, Monterrey, Veracruz
2023-03-09
Active, closed
Sanofi
Phase 3
91
Monterrey, Chihuahua City, Veracruz
2023-02-01
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Irapuato, Monterrey, Veracruz
2023-01-16
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
León, Guadalajara, Monterrey, Culiacán, Mérida, Veracruz
2023-01-16
By invitation
Tolmar Inc.
Phase 3
250
San Juan del Río, Guadalajara, Madero, Mexico City, Veracruz
2022-12-28
Recruiting
Pfizer
Phase 3
100
Veracruz
2022-12-09
Recruiting
Bayer
Phase 3
100
Aguascalientes, México D.F., México, D.F., Monterrey, Veracruz
2022-11-08
Active, closed
Eli Lilly and Company
Phase 3
377
Chihuahua City, Cuernavaca, Mexico City, Monterrey, Veracruz, Zapopan
2022-10-18
Active, closed
Gilead Sciences
Phase 3
1,021
México, Mitras Centro, Oaxaca City, Orizaba Centro, Puebla City, Veracruz
2022-10-12
Recruiting
GlaxoSmithKline
Phase 3
109
Guadalajara, Monterrey, Veracruz
2022-09-06
Active, closed
Sanofi
Phase 2/3
1,856
Monterrey, Durango, Veracruz
2022-08-22
Recruiting
Novartis Pharmaceuticals
Phase 2
240
Tampico, Mérida, Aguascalientes, Veracruz
2022-08-10
Active, closed
Hoffmann-La Roche
Phase 3
188
Guadalajara, Mexico City, Morelia, Culiacán, Veracruz
2022-05-19
Active, closed
Bayer
Phase 3
219
Aguascalientes, México, D.F., Veracruz
2022-03-28
Recruiting
Pfizer
Phase 3
160
Mexico City, Cuernavaca, Monterrey, Mérida, Aguascalientes, Veracruz
2022-03-07
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Guadalajara, San Pedro G G, Veracruz
2021-12-16
Active, closed
Immunic AG
Phase 3
1,121
Culiacán, Guadalajara, Mexico City, Morelia, Veracruz
2021-11-18
Active, closed
Sanofi
Phase 2
109
Mexico City, Monterrey, Mérida, Chihuahua City, Veracruz
2021-11-10
Recruiting
Pfizer
Phase 3
893
Colonia Valle de Las Palmas, Monterrey, Oaxaca City, Veracruz
2021-10-04
Active, closed
Bristol-Myers Squibb
Phase 3
670
Saltillo, Guadalajara, Mexico City, San Luis Potosí City, Mérida, Chihuahua City, Veracruz
2021-07-13
Active, closed
Tolmar Inc.
Phase 3
250
Mexico City, San Juan del Río, Veracruz
2021-07-01
Active, closed
Biogen
Phase 3
548
Guadalajara, Mexico City, Cuernavaca, Monterrey, Mérida, Chihuahua City, Durango, Veracruz
2021-05-25
Active, closed
Pfizer
Phase 3
599
León, Monterrey, Oaxaca City, Naucalpan, Veracruz
2021-05-12
Active, closed
AstraZeneca
Phase 3
1,157
Alc. Cuauhtémoc, Estado de México, Guadalajara, Metepec, Nuevo León, Veracruz
2021-04-26
Recruiting
Bristol-Myers Squibb
Phase 3
153
Guadalajara, Mexico City, Veracruz
2021-03-23
Active, closed
BioNTech SE
Phase 2/3
358
Tuxtla Gutiérrez, Chihuahua City, Guadalajara, Mexico City, Monterrey, Oaxaca City, Veracruz, Yucatán
2021-01-07
Active, closed
Medicago
Phase 2/3
30,918
Aguascalientes, Culiacán, Mexico City, Mérida, Puebla City, Veracruz, Zapopan
2020-11-19
Recruiting
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
NCT04256798Infection, Pneumonia, Surgical Site Infection, Wound Infection
DrugChlorhexidine mouthwash
University of Birmingham
Phase 3
12,942
Belisario Domínguez, Veracruz
2020-11-13
Active, closed
AstraZeneca
Phase 3
640
Chihuahua City, Cuernavaca, Mérida, Monterrey, Veracruz
2020-10-19
Active, closed
Hoffmann-La Roche
Phase 3
992
CD Mexico, Mexico City, Monterrey, Oaxaca City, San Luis Potosí City, Morelia, Veracruz
2020-10-09
Active, closed
AbbVie
Phase 3
527
Mexicali, Guadalajara, San Pedro Garza García, Mérida, Veracruz
2020-09-30
Active, closed
AstraZeneca
Phase 3
805
Aguascalientes, México, Monterrey, Oaxaca City, Querétaro, San Luis Potosí City, Veracruz
2020-05-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Mexico City, Cuernavaca, Chihuahua City, Veracruz
2020-02-27
Active, closed
Pfizer
Phase 3
896
Guadalajara, Monterrey, Chihuahua City, Irapuato, Veracruz
2019-09-05
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Distrito Federal, San Luis Potosí City, Veracruz
2019-03-15
Active, closed
Eli Lilly and Company
Phase 3
1,058
Chihuahua City, Culiacán, Veracruz
2018-07-18
Active, closed
Exelixis
Phase 3
837
Tuxtla Gutiérrez, León, Monterrey, Mexico City, San Luis Potosí City, Veracruz
2018-06-10
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Zapopan, Monterrey, Cancún, Mérida, Veracruz
2018-04-11
Rows per page Showing 1–91 of 91
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/veracruz

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 91 of those studies with a site in Veracruz.

How many clinical trials are recruiting in Veracruz?

36 of the 91 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 48 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Veracruz), 91 studies
PhaseStudiesRecruitingShare
Phase 3702876.9%
Phase 212713.2%
Phase 2/3505.5%
Observational414.4%

Most active sponsors

Lead sponsors with the most studies (Veracruz)
Lead sponsorStudiesRecruiting
Pfizer138
Sanofi111
Eli Lilly and Company105
AstraZeneca61
Bristol-Myers Squibb42
Hoffmann-La Roche41
AbbVie31
Boehringer Ingelheim32
Novartis Pharmaceuticals32
Bayer21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.